News

1Biomarkers and Clonal Dynamics Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain.
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
Bengaluru, India–based Biocon Biologics announced today that bevacizumab-nwgd (Jobevne), a biosimilar of bevacizumab (Avastin; Genentech), was approved by the FDA. Bevacizumab, which is given ...
Novartis announced it will spend $23 billion to construct and expand facilities in the United States. The planned investment includes six new manufacturing plants, including two radioligand therapy ...
This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.
1Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 2Division of Life Sciences and Medicine, Department of Urology, the First Affiliated ...
1State Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School and Hospital of ...
1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese ...
Gretchen M. Alicea; Payal Patel; Marie E. Portuallo; Mitchell E. Fane; Meihan Wei; Yash Chhabra; Agrani Dixit; Alexis E. Carey; Vania Wang; Murilo R. Rocha; Reeti ...
David Fandrei; Sabine Seiffert; Michael Rade; Susanne Rieprecht; Nico Gagelmann; Patrick Born; Thomas Wiemers; Heike Weidner; Markus Kreuz; Tamara Schassberger ...